Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease
Purpose
The aim of this study is to evaluate the effectiveness of MLS laser therapy as a treatment for pulmonary complications due to COVID-19 infection.
Condition
- COVID-19
Eligibility
- Eligible Ages
- Between 18 Years and 90 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- COVID-19 positive - Pulmonary compromise requiring oxygen support of approximately 2-6 liters - Able to self prone, or support in self-sitting position
Exclusion Criteria
- Ventilator management - Patients with autoimmune disorders or inflammatory conditions not related to COVID-19 - Pregnant women
Study Design
- Phase
- Phase 2
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Intervention Model Description
- This study will utilize a randomized parallel assignment
- Primary Purpose
- Treatment
- Masking
- None (Open Label)
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental Experimental |
Participants will receive MLS laser treatment along with regular inpatient medical care. |
|
|
Active Comparator Control Group |
Participants will receive regular inpatient medical care. |
|
Recruiting Locations
More Details
- NCT ID
- NCT04391712
- Status
- Completed
- Sponsor
- Lowell General Hospital
Detailed Description
Participants will be randomized into treatment vs. control group. Both groups will receive regular inpatient medical treatment. Participants in the experimental arm will receive laser treatments once daily for 4 days. Treatments will be delivered to the patients in a prone position using a 10 by 25 cm laser field across each lung with 7j/cm2 at 1500 Hz. Standard nursing protocols would be used to identify participant's pulmonary status throughout treatment.